The Strategic Research Initiative, a newly announced collaboration between the IU School of Medicine and IU Health, represents a bold step in developing innovative treatments for disease. Created through a $150 million investment, the new initiative will significantly enhance the partners’ joint capabilities in fundamental scientific investigation, translational research, and clinical trials.
IU Health, Indiana’s largest and most comprehensive health system, will invest $75 million in the new initiative, which the IU School of Medicine will match with an additional $75 million in resources. The initiative further strengthens and integrates the partners’ core academic medical center and its three-pronged mission of medical education, research, and patient care.
Initial collaborative efforts will be focused in the following key medical fields:
- Cancer: Provide funds to recruit leading cancer researchers and expand cancer clinical trials in Indiana to enable the IU Melvin and Bren Simon Cancer Center to attain status as one of the top-tier cancer centers in the nation as recognized by the National Cancer.
- Neuroscience: Address a broad range of brain injuries, neurodegenerative disorders and neurodevelopmental disorders.
- Cardiovascular: Implement a comprehensive program for the study and treatment of heart failure across all ages, and develop a cardiovascular genetics program.